Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4

Free Radical Biology and Medicine

Volumn 65, Issue , 2013, Pages 419-427

  Hauser, David N ^a   Dukes, April A ^a   Mortimer, Amanda D ^a   Hastings, Teresa G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine oxidation; GPx4; Mitochondrial dysfunction; Parkinson's disease; Selenoproteins

Indexed keywords

DOPAMINE; MITOCHONDRIAL PROTEIN; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; QUINONE DERIVATIVE; SELENOCYSTEINE; SELENOPROTEIN; DOPAMINE QUINONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 4, RAT;

ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; CELL VIABILITY; CONTROLLED STUDY; ELECTROPHILICITY; ENCEPHALE ISOLE; ENZYME ACTIVITY; NERVE CELL; NONHUMAN; NUCLEOPHILICITY; OXIDATION; PC12 CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RAT; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; DOPAMINERGIC NERVE CELL; IN VITRO STUDY; METABOLISM; PARKINSON DISEASE; PATHOPHYSIOLOGY; PC12 CELL LINE;

RATTUS;

ANIMALS; BLOTTING, WESTERN; DOPAMINE; DOPAMINERGIC NEURONS; GLUTATHIONE PEROXIDASE; IN VITRO TECHNIQUES; PARKINSON DISEASE; PC12 CELLS; RATS;

EID: 84881522331     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.06.030     Document Type: Article

References (66)

1. D.N. Hauser, and T.G. Hastings Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism Neurobiol. Dis. 51 2013 35 42
2. J.C. Martinou, and R.J. Youle Which came first, the cytochrome c release or the mitochondrial fission? Cell Death Differ. 13 2006 1291 1295 (Pubitemid 44057462)
3. S.A. Andrabi, T.M. Dawson, and V.L. Dawson Mitochondrial and nuclear cross talk in cell death: parthanatos Ann. N. Y. Acad. Sci. 1147 2008 233 241
4. M.R. Duchen Mitochondria and calcium: from cell signalling to cell death J. Physiol. 529 Pt 1 2000 57 68
5. A.A. Starkov The role of mitochondria in reactive oxygen species metabolism and signaling Ann. N. Y. Acad. Sci. 1147 2008 37 52
6. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A.R. Bentivoglio, D.G. Healy, A. Albanese, R. Nussbaum, R. Gonzalez-Maldonado, T. Deller, S. Salvi, P. Cortelli, W.P. Gilks, D.S. Latchman, R.J. Harvey, B. Dallapiccola, G. Auburger, and N.W. Wood Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160 (Pubitemid 38661852)
7. V. Bonifati, P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, E. Krieger, M.C. Dekker, F. Squitieri, P. Ibanez, M. Joosse, J.W. van Dongen, N. Vanacore, J.C. van Swieten, A. Brice, G. Meco, C.M. van Duijn, B.A. Oostra, and P. Heutink Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 299 2003 256 259 (Pubitemid 36131051)
8. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, M. Yokochi, Y. Mizuno, and N. Shimizu Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608 (Pubitemid 28207717)
9. G. Krebiehl, S. Ruckerbauer, L.F. Burbulla, N. Kieper, B. Maurer, J. Waak, H. Wolburg, Z. Gizatullina, F.N. Gellerich, D. Woitalla, O. Riess, P.J. Kahle, T. Proikas-Cezanne, and R. Kruger Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1 PLoS One 5 2010 e9367
10. D.P. Narendra, S.M. Jin, A. Tanaka, D.F. Suen, C.A. Gautier, J. Shen, M.R. Cookson, and R.J. Youle PINK1 is selectively stabilized on impaired mitochondria to activate Parkin PLoS Biol. 8 2010 e1000298
11. K.J. Thomas, M.K. McCoy, J. Blackinton, A. Beilina, M. van der Brug, A. Sandebring, D. Miller, D. Maric, A. Cedazo-Minguez, and M.R. Cookson DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy Hum. Mol. Genet 20 2011 40 50
12. D. Krige, M.T. Carroll, J.M. Cooper, C.D. Marsden, and A.H. Schapira Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group Ann. Neurol. 32 1992 782 788
13. I. Sipos, L. Tretter, and V. Adam-Vizi Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals J. Neurochem 84 2003 112 118 (Pubitemid 36182071)
14. A.H. Schapira, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269 (Pubitemid 19140359)
15. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980 (Pubitemid 13189531)
16. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
17. T.B. Sherer, J.H. Kim, R. Betarbet, and J.T. Greenamyre Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation Exp. Neurol. 179 2003 9 16 (Pubitemid 36062614)
18. J.R. Cannon, V. Tapias, H.M. Na, A.S. Honick, R.E. Drolet, and J.T. Greenamyre A highly reproducible rotenone model of Parkinson's disease Neurobiol. Dis. 34 2009 279 290
19. J.T. Greenamyre, J.R. Cannon, R. Drolet, and P.G. Mastroberardino Lessons from the rotenone model of Parkinson's disease Trends Pharmacol. Sci. 31 2010 141 142
20. D.G. Graham, S.M. Tiffany, W.R. Bell Jr, and W.F. Gutknecht Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro Mol. Pharmacol. 14 1978 644 653 (Pubitemid 8402470)
21. T.G. Hastings, D.A. Lewis, and M.J. Zigmond Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections Proc. Natl. Acad. Sci. USA 93 1996 1956 1961 (Pubitemid 26079862)
22. W.M. Caudle, J.R. Richardson, M.Z. Wang, T.N. Taylor, T.S. Guillot, A.L. McCormack, R.E. Colebrooke, D.A. Di Monte, P.C. Emson, and G.W. Miller Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration J. Neurosci. 27 2007 8138 8148 (Pubitemid 47173329)
23. R.E. Huber, and R.S. Criddle Comparison of the chemical properties of selenocysteine and selenocystine with their sulfur analogs Arch. Biochem. Biophys. 122 1967 164 173
24. S.C. Low, E. Grundner-Culemann, J.W. Harney, and M.J. Berry SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy EMBO J. 19 2000 6882 6890 (Pubitemid 32011681)
25. L.J. Yant, Q. Ran, L. Rao, H. Van Remmen, T. Shibatani, J.G. Belter, L. Motta, A. Richardson, and T.A. Prolla The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults Free Radic. Biol. Med. 34 2003 496 502 (Pubitemid 36140174)
26. M. Maiorino, K.D. Aumann, R. Brigelius-Flohe, D. Doria, J. van den Heuvel, J. McCarthy, A. Roveri, F. Ursini, and L. Flohe Probing the presumed catalytic triad of selenium-containing peroxidases by mutational analysis of phospholipid hydroperoxide glutathione peroxidase (PHGPx) Biol. Chem. Hoppe Seyler 376 1995 651 660 (Pubitemid 3009515)
27. Y. Zhang, Y. Zhou, U. Schweizer, N.E. Savaskan, D. Hua, J. Kipnis, D.L. Hatfield, and V.N. Gladyshev Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals J. Biol. Chem. 283 2008 2427 2438
28. E. Panfili, G. Sandri, and L. Ernster Distribution of glutathione peroxidases and glutathione reductase in rat brain mitochondria FEBS Lett. 290 1991 35 37
29. R.H. Houtkooper, and F.M. Vaz Cardiolipin, the heart of mitochondrial metabolism Cell. Mol. Life Sci. 65 2008 2493 2506
30. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem 72 1976 248 254
31. L.P. Zhang, M. Maiorino, A. Roveri, and F. Ursini Phospholipid hydroperoxide glutathione peroxidase: specific activity in tissues of rats of different age and comparison with other glutathione peroxidases Biochim. Biophys. Acta 1006 1989 140 143 (Pubitemid 19264824)
32. V.S. Van Laar, A.A. Dukes, M. Cascio, and T.G. Hastings Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease Neurobiol. Dis. 29 2008 477 489
33. A.A. Dukes, V.S. Van Laar, M. Cascio, and T.G. Hastings Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine J. Neurochem. 106 2008 333 346 (Pubitemid 351840216)
34. 2 in red blood cells Antioxid. Redox Signal. 12 2010 1235 1246
35. A. Suryo Rahmanto, D.I. Pattison, and M.J. Davies Photo-oxidation-induced inactivation of the selenium-containing protective enzymes thioredoxin reductase and glutathione peroxidase Free Radic. Biol. Med. 53 2012 1308 1316
36. F. Ursini, S. Heim, M. Kiess, M. Maiorino, A. Roveri, J. Wissing, and L. Flohe Dual function of the selenoprotein PHGPx during sperm maturation Science 285 1999 1393 1396 (Pubitemid 29411669)
37. E. Belluzzi, M. Bisaglia, E. Lazzarini, L.C. Tabares, M. Beltramini, and L. Bubacco Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease PloS One 7 2012 e38026
38. K.A. Conway, J.C. Rochet, R.M. Bieganski, and P.T. Lansbury Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346 1349 (Pubitemid 33063102)
39. S. Girotto, M. Sturlese, M. Bellanda, I. Tessari, R. Cappellini, M. Bisaglia, L. Bubacco, and S. Mammi Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53 J. Biol. Chem. 287 2012 18738 18749
40. M.J. LaVoie, B.L. Ostaszewski, A. Weihofen, M.G. Schlossmacher, and D.J. Selkoe Dopamine covalently modifies and functionally inactivates parkin Nat. Med 11 2005 1214 1221 (Pubitemid 43093669)
41. V.S. Van Laar, A.J. Mishizen, M. Cascio, and T.G. Hastings Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells Neurobiol. Dis. 34 2009 487 500
42. D.A. Bota, and K.J. Davies Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism Nat. Cell Biol. 4 2002 674 680 (Pubitemid 34993703)
43. J.K. Ngo, L.C. Pomatto, D.A. Bota, A.L. Koop, and K.J. Davies Impairment of lon-induced protection against the accumulation of oxidized proteins in senescent wi-38 fibroblasts J. Gerontol. A Biol. Sci. Med. Sci 66 2011 1178 1185
44. P. Scheerer, A. Borchert, N. Krauss, H. Wessner, C. Gerth, W. Hohne, and H. Kuhn Structural basis for catalytic activity and enzyme polymerization of phospholipid hydroperoxide glutathione peroxidase-4 (GPx4) Biochemistry 46 2007 9041 9049 (Pubitemid 47237379)
45. F.P. Bellinger, M.T. Bellinger, L.A. Seale, A.S. Takemoto, A.V. Raman, T. Miki, A.B. Manning-Bog, M.J. Berry, L.R. White, and G.W. Ross Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson's brain Mol. Neurodegener 6 2011 8
46. L. Zecca, D. Tampellini, M. Gerlach, P. Riederer, R.G. Fariello, and D. Sulzer Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour Mol. Pathol 54 2001 414 418 (Pubitemid 34025257)
47. J. Chen, and M.J. Berry Selenium and selenoproteins in the brain and brain diseases J. Neurochem. 86 2003 1 12 (Pubitemid 36753840)
48. K.E. Hill, J. Zhou, W.J. McMahan, A.K. Motley, and R.F. Burk Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene J. Nutr. 134 2004 157 161 (Pubitemid 38057440)
49. W.M. Valentine, T.W. Abel, K.E. Hill, L.M. Austin, and R.F. Burk Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2 J. Neuropathol. Exp. Neurol. 67 2008 68 77
50. M.A. Reeves, and P.R. Hoffmann The human selenoproteome: recent insights into functions and regulation Cell. Mol. Life Sci. 66 2009 2457 2478
51. M. Schneider, H. Forster, A. Boersma, A. Seiler, H. Wehnes, F. Sinowatz, C. Neumuller, M.J. Deutsch, A. Walch, M. Hrabe de Angelis, W. Wurst, F. Ursini, A. Roveri, M. Maleszewski, M. Maiorino, and M. Conrad Mitochondrial glutathione peroxidase 4 disruption causes male infertility FASEB J 23 2009 3233 3242
52. H. Liang, S.E. Yoo, R. Na, C.A. Walter, A. Richardson, and Q. Ran Short form glutathione peroxidase 4 is the essential isoform required for survival and somatic mitochondrial functions J. Biol. Chem. 284 2009 30836 30844
53. A. Seiler, M. Schneider, H. Forster, S. Roth, E.K. Wirth, C. Culmsee, N. Plesnila, E. Kremmer, O. Radmark, W. Wurst, G.W. Bornkamm, U. Schweizer, and M. Conrad Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death Cell Metab. 8 2008 237 248
54. S.E. Yoo, L. Chen, R. Na, Y. Liu, C. Rios, H. Van Remmen, A. Richardson, and Q. Ran Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain Free Radic. Biol. Med. 2012
55. L. Chen, R. Na, M. Gu, A. Richardson, and Q. Ran Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease J. Neurochem. 107 2008 197 207
56. M.H. Yoo, X. Gu, X.M. Xu, J.Y. Kim, B.A. Carlson, A.D. Patterson, H. Cai, V.N. Gladyshev, and D.L. Hatfield Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease Antioxid. Redox Signal. 12 2010 819 827
57. H. Imai, and Y. Nakagawa Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells Free Radic. Biol. Med. 34 2003 145 169 (Pubitemid 36084320)
58. K. Nomura, H. Imai, T. Koumura, M. Arai, and Y. Nakagawa Mitochondrial phospholipid hydroperoxide glutathione peroxidase suppresses apoptosis mediated by a mitochondrial death pathway J. Biol. Chem. 274 1999 29294 29302
59. Q. Ran, M. Gu, H. Van Remmen, R. Strong, J.L. Roberts, and A. Richardson Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity J. Neurosci. Res. 84 2006 202 208 (Pubitemid 44023075)
60. H. Imai, T. Koumura, R. Nakajima, K. Nomura, and Y. Nakagawa Protection from inactivation of the adenine nucleotide translocator during hypoglycaemia-induced apoptosis by mitochondrial phospholipid hydroperoxide glutathione peroxidase Biochem. J. 371 2003 799 809 (Pubitemid 36578879)
61. K. Nomura, H. Imai, T. Koumura, T. Kobayashi, and Y. Nakagawa Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis Biochem. J 351 2000 183 193
62. D.T. Dexter, C.J. Carter, F.R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner, and C.D. Marsden Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J. Neurochem. 52 1989 381 389 (Pubitemid 19037600)
63. D.T. Dexter, A.E. Holley, W.D. Flitter, T.F. Slater, F.R. Wells, S.E. Daniel, A.J. Lees, P. Jenner, and C.D. Marsden Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study Mov. Disord 9 1994 92 97 (Pubitemid 24022621)
64. E. Garcia, D. Limon, V. Perez-De La Cruz, M. Giordano, M. Diaz-Munoz, P.D. Maldonado, M.N. Herrera-Mundo, J. Pedraza-Chaverri, and A. Santamaria Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine Free Radic. Res. 42 2008 892 902
65. J.J. Palacino, D. Sagi, M.S. Goldberg, S. Krauss, C. Motz, M. Wacker, J. Klose, and J. Shen Mitochondrial dysfunction and oxidative damage in parkin-deficient mice J. Biol. Chem. 279 2004 18614 18622 (Pubitemid 38623283)
66. Bösl, M.R.; Takaku, K.; Oshima, M.; Nishimura, S.; Taketo, MM.; PMID 9159106.Proc. Natl. Acad. Sci. USA. 94(11):5531-4;1997. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp).